EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) for its WiSE (Wireless Stimulation Endocardially) Technology for...
Heart Failure
-
-
The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea.
-
September 2, 2016 — Results from an international, randomized study show that an implanted nerve stimulator significantly improves symptoms in those with central sleep apnea (CSA), without causing...
-
August 23, 2016 — During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells within the tissue. But the damage doesn’t end after the crushing pain subsides.
News | Heart Failure | September 20, 2016
September 20, 2016 — Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to...
The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.
News | Cardiac Resynchronization Therapy Devices (CRT) | September 15, 2016
September 15, 2016 — EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an...
News | Artificial Heart | September 13, 2016
August 29, 2016 — SynCardia Systems, manufacturer of the...
News | Artificial Heart | September 09, 2016
September 9, 2016 — Carmat announced that the first implantation of its bioprosthetic...
Videos | Heart Failure | September 02, 2016
The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by...
The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea.
News | Heart Failure | September 02, 2016
September 2, 2016 — Results from an international, randomized study show that an implanted nerve stimulator...
News | Heart Failure | August 23, 2016
August 23, 2016 — A new study of more than 13,000 people has found that so-called morbid obesity appears to stand...
Compared to other types of hydrogels being developed (left), a new hydrogel (right) can form crosslinks after injection into the heart, making the material stiffer and longer-lasting. Image courtesy of American Chemical Society.
News | Heart Failure | August 23, 2016
August 23, 2016 — During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells...
News | Ventricular Assist Devices (VAD) | August 11, 2016
August 11, 2016 — Carew Medical Wear Inc., a custom medical outfit company specializing in...
News | Heart Failure | August 09, 2016
August 9, 2016 – With the use of intensive care units (ICUs) on the rise in many hospitals, researchers at LA BioMed...
News | Heart Failure | July 22, 2016
July 22, 2016 — CardioKinetix Inc. announced this week that 500 patients have received the company’s Parachute...
News | Heart Failure | July 08, 2016
July 8, 2016 — University of Guelph researchers have uncovered a possible clue as to why women have lower rates of...
News | Business | July 07, 2016
July 7, 2016 — SynCardia Systems Inc. announced that it has entered into an...
News | Heart Failure | July 05, 2016
July 5, 2016 — A research team has developed a new electric mesh device that can be wrapped around the heart to...
News | Ventricular Assist Devices (VAD) | July 05, 2016
July 5, 2016 — HeartWare Inc. announced a recall of the batteries used on the...
